FURIN and hepatocellular carcinoma: Safety and efficient immune response of an autologous tumor cell vaccine (FANG) that combines furin shRNA and expression of GM-CSF were confirmed and benefits of treatment were observed from phase I trials in Ewing sarcoma and hepatocellular carcinoma patients [46–48].